The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system

Medical Mycology

Volumn 50, Issue 5, 2012, Pages 488-496

  Muhammed, Maged ^a   Fuchs, Beth Burgwyn ^a   Wu, Michael P ^a   Breger, Julia ^a   Coleman, Jeffrey J ^a   Mylonakis, Eleftherios ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Caenorhabditis elegans; Fusarium; Host; Mancozeb

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; MANCOZEB; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLMERCURIC ACETATE; PMK 1 PROTEIN; TIR 1 PROTEIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DRUG EFFICACY; FUNGAL STRAIN; FUSARIUM PROLIFERATUM; GENE; GENETIC CONSERVATION; HOST PARASITE INTERACTION; IMMUNE RESPONSE; MYCELIUM; MYCOSIS; NONHUMAN; SURVIVAL RATE; WILD TYPE;

ANIMALS; ANTIFUNGAL AGENTS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; DISEASE MODELS, ANIMAL; FUSARIOSIS; FUSARIUM; HOST-PATHOGEN INTERACTIONS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MYCELIUM; SIGNAL TRANSDUCTION;

EID: 84862157744     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.648217     Document Type: Article

References (60)

1. Nucci M, Anaissie E. Emerging fungi. I nfect Dis Clin North Am 2006; 20 : 563-579. (Pubitemid 44389926)
2. Nucci M, Anaissie E. F usarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20 : 695-704.
3. Campo M, Lewis RE, Kontoyiannis DP. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect 2010; 60 : 331-337.
4. Maschmeyer G, Calandra T, Singh N, Wiley J, Perfect J. Invasive mould infections: A multi-disciplinary update. Med Mycol 2009; 47 : 571-583.
5. Boutati EI, Anaissie EJ. F usarium , a signifi cant emerging pathogen in patients with hematologic malignancy: ten years'experience at a cancer center and implications for management. Blood 1997; 90 : 999-1008. (Pubitemid 27314133)
6. Nucci M, Anaissie EJ, Queiroz-Telles F, et al . Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003; 98 : 315-319. (Pubitemid 36828456)
7. Muhammed M, Coleman JJ, Carneiro HA, Mylonakis E. The challenge of managing fusariosis. Virulence 2011; 2 : 91-96.
8. Patterson TF, Mackool BT, Gilman MD, Piris A. Case records of the Massachusetts General Hospital. Case 22-2009. A 59-year-old man with skin and pulmonary lesions after chemotherapy for leukemia [corrected]. N Engl J Med 2009; 361 : 287-296.
9. Perfect J.R. Treatment of non- Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis 2005; 40 (Suppl. 6): S401-408 (Pubitemid 40563297)
10. Vagace JM, Sanz-Rodriguez C, Casado MS, et al . Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: A case report. BMC Infect Dis 2007; 7 : 40.
11. Stanzani M, Vianelli N, Bandini G, et al . Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect 2006; 53 : e243-246. (Pubitemid 44688987)
12. Carneiro HA, Coleman JJ, Restrepo A, Mylonakis E. Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine ( Baltimore ) 2011; 90 : 69-80.
13. Kaletta T, Hengartner MO. Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov 2006; 5 : 387-398.
14. Artal-Sanz M, de Jong L, Tavernarakis N. C aenorhabditis elegans : A versatile platform for drug discovery. Biotechnol J 2006; 1 : 1405-1418.
15. Breger J, Fuchs BB, Aperis G, et al . Antifungal chemical compounds identifi ed using a C. elegans pathogenicity assay. PLoS Pathog 2007; 3 : e18.
16. Moy TI, Ball AR, Anklesaria Z, et al . Identifi cation of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci USA 2006; 103 : 10414-10419. (Pubitemid 44051181)
17. Sifri CD, Begun J, Ausubel FM. The worm has turned-microbial virulence modeled in Caenorhabditis elegans . Trends Microbiol 2005; 13 : 119-127. (Pubitemid 40311894)
18. Mylonakis E, Casadevall A, Ausubel FM. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog 2007; 3 : e101.
19. Mylonakis E, Idnurm A, Moreno R, et al . Cryptococcus neoformans Kin1 protein kinase homologue, identifi ed through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol Microbiol 2004; 54 : 407-419. (Pubitemid 39388285)
20. Tang RJ, Breger J, Idnurm A, et al . Cryptococcus neoformans gene involved in mammalian pathogenesis identifi ed by a Caenorhabditis elegans progeny-based approach. Infect Immun 2005; 73 : 8219-8225. (Pubitemid 41740311)
21. Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E. C andida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell 2009; 8 : 1750-1758.
22. Pujol N, Zugasti O, Wong D, et al . Anti-fungal innate immunity in C. elegans is enhanced by evolutionary diversifi cation of antimicrobial peptides. PLoS Pathog 2008; 4 : e1000105.
23. Lee KZ, Kniazeva M, Han M, Pujol N, Ewbank JJ. The fatty acid synthase fasn-1 acts upstream of WNK and Ste20/GCK-VI kinases to modulate antimicrobial peptide expression in C. elegans epidermis. Virulence 2010; 1 : 113-122.
24. Pukkila-Worley R, Mylonakis E. From the outside in and the inside out: Antifungal immune responses in Caenorhabditis elegans . Virulence 2010; 1 : 111-112.
25. Zugasti O, Ewbank JJ. Neuroimmune regulation of antimicrobial peptide expression by a noncanonical TGF-beta signaling pathway in Caenorhabditis elegans epidermis. Nat Immunol 2009; 10 : 249-256.
26. Pukkila-Worley R, Ausubel FM, Mylonakis E. C andida albicans infection of Caenorhabditis elegans induces antifungal immune defenses. PLoS Pathog 2011; 7 : e1002074.
27. Simonsen KT, Moller-Jensen J, Kristensen AR, et al . Quantitative proteomics identifi es ferritin in the innate immune response of C. elegans . Virulence 2011; 2 : 120-130.
28. Krishnan J, Selvarajoo K, Tsuchiya M, Lee G, Choi S. Toll-like receptor signal transduction. Exp Mol Med 2007; 39 : 421-438. (Pubitemid 47443856)
29. Gil ML, Gozalbo D. TLR2, but not TLR4, triggers cytokine production by murine cells in response to Candida albicans yeasts and hyphae. Microbes Infect 2006; 8 : 2299-2304. (Pubitemid 44311598)
30. Brown GD. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol 2011; 29 : 1-21.
31. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and infl ammation. Physiol Rev 2001; 81 : 807-869. (Pubitemid 32267078)
32. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004; 68 : 320-344. (Pubitemid 38756868)
33. Liberati NT, Fitzgerald KA, Kim DH, et al . Requirement for a conserved Toll/interleukin-1 resistance domain protein in the Caenorhabditis elegans immune response. Proc Natl Acad Sci USA 2004; 101 : 6593-6598. (Pubitemid 38586019)
34. Troemel ER, Chu SW, Reinke V, et al . p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans . PLoS Genet 2006; 2 : e183.
35. Shivers RP, Pagano DJ, Kooistra T, et al . Phosphorylation of the conserved transcription factor ATF-7 by PMK-1 p38 MAPK regulates innate immunity in Caenorhabditis elegans . PLoS Genet 2010; 6 : e1000892.
36. O'Donnell K, Kistler HC, Cigelnik E, Ploetz RC. Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies. Proc Natl Acad Sci USA 1998; 95 : 2044-2049. (Pubitemid 28145891)
37. O'Donnell K, Sutton DA, Fothergill A, et al . Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol 2008; 46 : 2477-2490.
38. O'Donnell K, Gueidan C, Sink S, et al . A two-locus DNA sequence database for typing plant and human pathogens within the Fusarium oxysporum species complex. Fungal Genet Biol 2009; 46 : 936-948.
39. O'Donnell K, Sutton DA, Rinaldi MG, et al . Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 2010; 48 : 3708-3718.
40. McCluskey K, Wiest A, Plamann M. The Fungal Genetics Stock Center: A repository for 50 years of fungal genetic research. J Biosci 2010; 35 : 119-126.
41. Couillault C, Pujol N, Reboul J, et al . TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat Immunol 2004; 5 : 488-494. (Pubitemid 38660460)
42. Tenor JL, Aballay A. A conserved Toll-like receptor is required for Caenorhabditis elegans innate immunity. EMBO Rep 2008; 9 : 103-109.
43. Yeates GW, Bongers T, De Goede RG, Freckman DW, Georgieva SS. Feeding habits in soil nematode families and genera-an outline for soil ecologists. J Nematol 1993; 25 : 315-331.
44. Vu TT, Sikora RA, Hauschild R. Effects of endophytic F usarium oxysporum towards Radopholus similis activity in absence of banana. Commun Agric Appl Biol Sci 2004; 69 : 381-385.
45. Voss KA, Riley RT, Norred WP, et al . An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme . Environ Health Perspect 2001; 109 (Suppl. 2): 259-266. (Pubitemid 32492786)
46. Bennett JW, Klich M. Mycotoxins. Clin Microbiol Rev 2003; 1 6 : 497-516. (Pubitemid 36871318)
47. Jain A, Mohan J, Singh M, Goswami BK. Potentiality of different isolates of wilt fungus Fusarium oxysporum collected from rhizosphere of tomato against root-knot nematode Meloidogyne incognita . J Environ Sci Health B 2008; 43 : 686-691.
48. Shimada A, Fujioka S, Koshino H, Kimura Y. Nematicidal activity of beauvericin produced by the fungus Fusarium bulbicola . Z Naturforsch C 2010; 65 : 207-210.
49. Athman SY, Dubois T, Coyne D, et al . Effect of endophytic F usarium oxysporum on host preference of Radopholus similis to tissue culture banana plants. J Nematol 2006; 38 : 455-460. (Pubitemid 46570508)
50. Kokkonen M, Ojala L, Parikka P, Jestoi M. Mycotoxin production of selected Fusarium species at different culture conditions. Int J Food Microbiol 2010; 143: 17-25.
51. Waskiewicz A, Golinski P, Karolewski Z, et al . Formation of fumonisins and other secondary metabolites by Fusarium oxysporum and F. proliferatum : A comparative study. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2010; 27 : 608-615.
52. Reverberi M, Ricelli A, Zjalic S, Fabbri AA, Fanelli C. Natural functions of mycotoxins and control of their biosynthesis in fungi. Appl Microbiol Biotechnol ; 87 : 899-911.
53. Johnson CH, Ayyadevara S, McEwen JE, Shmookler Reis RJ. Histoplasma capsulatum and Caenorhabditis elegans : A simple nematode model for an innate immune response to fungal infection. Med Mycol 2009; 47 : 808-813.
54. Legrand C, Anaissie E, Hashem R, et al . Experimental fusarial hyalohyphomycosis in a murine model. J Infect Dis 1991; 164 : 944-948.
55. Means TK, Mylonakis E, Tampakakis E, et al . Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med 2009; 206 : 637-653.
56. Okoli I, Coleman JJ, Tampakakis E, et al . Identifi cation of antifungal compounds active against Candida albicans using an improved highthroughput Caenorhabditis elegans assay. PLoS One 2009; 4 : e7025.
57. Moy TI, Conery AL, Larkins-Ford J, et al . High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol 2009; 4 : 527-533.
58. Chaturvedi S, Rajkumar SS, Li X, et al . Antifungal testing and high-throughput screening of compound library against Geomyces destructans , the etiologic agent of geomycosis (WNS) in bats. PLoS One 2011; 6 : e17032.
59. Coleman J, Muhammed M, Kasperkovitz P, Vyas J, Mylonakis E. Fusarium pathogenesis investigated using Galleria mellonella as a heterologous host. Fungal Biology 2011; 115 : 1279-1289.
60. Lamaris GA, Chamilos G, Lewis RE, Kontoyiannis DP. Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster . J Infect Dis 2007; 196 : 1860-1864. (Pubitemid 351411948)